Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001415889-15-001153
Filing Date
2015-03-31
Accepted
2015-03-31 15:37:36
Documents
14
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K innv10k_dec312014.htm 10-K 1488198
2 OFFER LETTER, DATED FEBRUARY 6, 2014, BETWEEN INNOVUS PHARMACEUTICALS, INC. AND ex10-24.htm EX-10.24 540
3 CODE OF ETHICS. ex14-1.htm EX-14.1 20985
4 LIST OF SUBSIDIARIES ex21-1.htm EX-21.1 4513
5 CONSENT OF EISNERAMPER LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. ex23-1.htm EX-23.1 3901
6 CERTIFICATION OF THE REGISTRANT?S PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECURI ex31-1.htm EX-31.1 11655
7 CERTIFICATION OF THE REGISTRANT?S PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECURI ex31-2.htm EX-31.2 11686
8 CERTIFICATION OF THE REGISTRANT?S PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINA ex32-1.htm EX-32.1 10141
  Complete submission text file 0001415889-15-001153.txt   6454251

Data Files

Seq Description Document Type Size
9 innv-20141231.xml EX-101.INS 648210
10 innv-20141231.xsd EX-101.SCH 47441
11 innv-20141231_cal.xml EX-101.CAL 52354
12 innv-20141231_def.xml EX-101.DEF 235790
13 innv-20141231_lab.xml EX-101.LAB 375850
14 innv-20141231_pre.xml EX-101.PRE 318878
Mailing Address 4275 EXECUTIVE SQUARE, SUITE 200 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE, SUITE 200 LA JOLLA CA 92037 858-964-5123
INNOVUS PHARMACEUTICALS, INC. (Filer) CIK: 0001411879 (see all company filings)

EIN.: 870324697 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52991 | Film No.: 15738940
SIC: 2834 Pharmaceutical Preparations